相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Advances in Copper Complexes as Anticancer Agents
Carlo Santini et al.
CHEMICAL REVIEWS (2014)
Improving nuclease activity of copper(II)-terpyridine complex through solubilizing and charge effects of glycine
Wen Zhou et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2013)
In Vitro and in Vivo Anticancer Activity of Copper Bis(thiosemicarbazone) Complexes
Duraippandi Palanimuthu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
The targeted inhibition of mitochondrial Hsp90 overcomes the apoptosis resistance conferred by Bcl-2 in Hep3B cells via necroptosis
Chunlan Yan et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
Enzyme inhibition by metal complexes: concepts, strategies and applications
Kelly J. Kilpin et al.
CHEMICAL SCIENCE (2013)
Next-Generation Anticancer Metallodrugs
Seiji Komeda et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2012)
The oncology drug elesclomol selectively transports copper to the mitochondria to induce oxidative stress in cancer cells
Masazumi Nagai et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Mechanisms underlying reductant-induced reactive oxygen species formation by anticancer copper(II) compounds
Christian R. Kowol et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2012)
1,10-Phenanthroline promotes copper complexes into tumor cells and induces apoptosis by inhibiting the proteasome activity
Zhen Zhang et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2012)
Copper-Dependent Cytotoxicity of 8-Hydroxyquinoline Derivatives Correlates with Their Hydrophobicity and Does Not Require Caspase Activation
Saverio Tardito et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Platinum Formulations as Anticancer Drugs Clinical and Pre-Clinical Studies
Nicholas P. Farrell
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2011)
Cytotoxic copper (II) mixed ligand complexes: Crystal structure and DNA cleavage activity
Verasuntharam M. Manikandamathavan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Exploiting the mitochondrial unfolded protein response for cancer therapy in mice and human cells
Markus D. Siegelin et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Fresh Platinum Complexes with Promising Antitumor Activity
Xiaoyong Wang
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2010)
Posttranslational regulation of copper transporters
Peter V. E. van den Berghe et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2010)
Preclinical Evaluation of Novel Triphenylphosphonium Salts with Broad-Spectrum Activity
Melissa Millard et al.
PLOS ONE (2010)
Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism
Divya Pathania et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Copper Complexes as Anticancer Agents
Cristina Marzano et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2009)
Elevated copper and oxidative stress in cancer cells as a target for cancer treatment
Anshul Gupte et al.
CANCER TREATMENT REVIEWS (2009)
Synthesis, characterization, and cytotoxicity of dinuclear platinum-bisphosphonate complexes to be used as prodrugs in the local treatment of bone tumours
Nicola Margiotta et al.
DALTON TRANSACTIONS (2009)
Arylphosphonium salts interact with DNA to modulate cytotoxicity
Krystal L. Bergeron et al.
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS (2009)
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Dunyaporn Trachootham et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Targeting lipophilic cations to mitochondria
Michael P. Murphy
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2008)
Platinum resistance: The role of DNA repair pathways
Lainie P. Martin et al.
CLINICAL CANCER RESEARCH (2008)
Towards the rational design of platinum(II) and gold(III) complexes as antitumour agents
Xiaoyong Wang et al.
DALTON TRANSACTIONS (2008)
Resistance against novel anticancer metal compounds: Differences and similarities
Petra Heffeter et al.
DRUG RESISTANCE UPDATES (2008)
Effects of targeting moiety, linker, bifunctional chelator, and molecular charge on biological properties of 64Cu-labeled triphenylphosphonium cations
Young-Seung Kim et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Mitochondrial medicine: Pharmacological targeting of mitochondria in disease
J. S. Armstrong
BRITISH JOURNAL OF PHARMACOLOGY (2007)
64Cu-Labeled triphenylphosphonium and triphenylarsonium cations as highly tumor-selective imaging agents
Jianjun Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
The resurgence of platinum-based cancer chemotherapy
Lloyd Kelland
NATURE REVIEWS CANCER (2007)
Mitochondrial membrane permeabilization in cell death
Guido Kroemer et al.
PHYSIOLOGICAL REVIEWS (2007)
Solid-phase synthesis, characterization and DNA binding properties of the first chloro(polypyridyl)ruthenium conjugated peptide complex
K Karidi et al.
DALTON TRANSACTIONS (2005)
The pathophysiology of mitochondrial cell death
DR Green et al.
SCIENCE (2004)
Biochemical and genetic analyses of yeast and human high affinity copper transporters suggest a conserved mechanism for copper uptake
S Puig et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells
JS Modica-Napolitano et al.
ADVANCED DRUG DELIVERY REVIEWS (2001)
Mitochondrial control of cell death
G Kroemer et al.
NATURE MEDICINE (2000)
分享论文
